Dr. Cheryl Dileo is a Board-Certified music therapist with a number of years of experience as a clinician, consultant educator and researcher. She currently coordinates the PhD Program in Music Therapy in Philadelphia and Tokyo and is the Director of the Arts and Quality of Life Research Center at Temple University. She received her B.M.T., and MMT in Music therapy from Loyola University of the South and her Ph.D.in Music Education for College Teaching, from Louisiana State University. She founded the music therapy program at the University of Evansville, was the Consultant for the development of the Music Therapy program at Berklee College of Music, and has served on the music therapy faculty at Loyola University. She was named the McAndless Distinguished Scholar and Professor in the Humanities for the 2002-3 academic year at Eastern Michigan University. She is currently on the Honorary Faculty at the University of Melbourne Australia, and a member of the PhD Program Advisory Board at Aalborg University, Denmark. She has served on the Editorial Board of the Journal of Music Therapy, Music Therapy: The Journal of the American Association for Music Therapy, the International Journal of Arts in Psychotherapy and Music I Health (Germany). She has also served as Co-Editor for Voices, and currently serves as a Consulting Editor for The Nordic Journal of Music Therapy.
Dr. Dileo is a Past-President of the World Federation of Music Therapy and the National Association for Music Therapy (USA). She is Vice President of the International Society for Music in Medicine and a Founding Member of the International Association of Music and Medicine.
The American Music Therapy Association has honored her with the Lifetime Achievement Award, the Award of Merit, as well as the Distinguished Research/Publication Award. She was the recipient of the 2006 Temple University Faculty Research Award. She recently received the 2018 Adjutor Hominum Award from Loyola University.
She has given more than 300 lectures and workshops on 5 continents. She has authored/edited co-edited 16 books and over 100 book chapters and journal articles. Currently, she is a co-author of 7 Cochrane systematic reviews on medical music therapy for the Cochrane Library. She has received over $750,000 of grant funding from a variety of sources, including the State of PA Formula Fund and the Barra Foundation.
Cheryl Dileo, PhD The Laura H. Carnell Professor of Music Therapy
Coordinator, PhD Program in Music Therapy
Director, Arts and Quality of Life Research Center
Dr. Alexandra J. Fiocco obtained an MSc in Psychology with specialization in Neuroscience from Carleton University in 2002, followed by a PhD in Neuroscience from McGill in 2008. After completing postdoctoral training in clinical and epidemiological research methods at the University of California San Francisco and at Baycrest Centre in Toronto, Dr. Fiocco joined the Department of Psychology at Ryerson University in 2011. She is currently an Associate Professor and Director of the Stress and Healthy Aging Research Lab at Ryerson where she and her team examine biological and psychosocial predictors of cognitive health and emotional wellbeing in late life. Dr. Fiocco’s program of research also investigates the effect of interventions on cognitive and emotional wellbeing among older adults living independently in the community and older adults living in residential care. One particular intervention of interest is mindfulness-based stress reduction.
Alexandra Fiocco, PhD Associate Professor
Department of Psychology
Dr. François Haman’s research deals with all aspects of human energetics. It focuses on how humans orchestrate metabolic fuel selection to improve chances of survival and increase performance in adverse environmental conditions such as changing climates and important modifications of dietary behavior. From mechanisms to applications, his work aims to establish principles that dictate fuel use and provide strategies to improve health/performance or chances of survival using alterations in dietary behaviors or physical training. Current work integrates a number of state-of-the-art metabolic methodologies to quantify human responses to climate change (heat/cold) and to provide dietary strategies to reduce the prevalence of obesity and obesity related diseases in First Nations communities of Northwestern Ontario.
François Haman, PhD Professor
Faculty of Health Sciences
University of Ottawa
Dr. Mary Jung is an associate professor in the School of Health and Exercise Sciences at the University of British Columbia, Okanagan Campus in Kelowna, BC. Dr. Jung is a Michael Smith Foundation for Health Research Scholar, and a Canadian Institutes of Health Research Early Career Foundation Grant recipient. Her overarching research interests lie in the area of self-regulation of health behaviours, with particular focus on exercise adherence for the prevention of type 2 diabetes. Dr. Jung’s current funded studies span health program evaluation, effectiveness of mHealth technologies, exercise counselling for individuals with prediabetes, exercise adherence RCTs, and nationwide nutrition campaigns. She directs the Diabetes Prevention Research Group at UBC Okanagan.
Mary Jung, PhD Associate Professor
Faculty of Health and Social Development University of British Columbia
Dr. Arno Villringer received his MD from University of Freiburg, did a postdoc at the MGH, Harvard Medical School, Boston, his clinical residency (Neurology) at the University Hospital Munich, was a consultant and subsequent head of Dept. of Neurology at Charité hospital (Campus Benjamin Franklin) in Berlin. Since 2007 he is the Max Planck Director of the Department of Neurology (Human Cognitive and Brain Sciences, Leipzig), Director of the Cognitive Neurology Clinic of the University Hospital of Leipzig, and Academic Director of the Berlin School of Mind and Brain at Charité and Humboldt-University Berlin. He pursues research on (i) neurocognition of vascular risk factors (obesity, hypertension) and prevention of subsequent stroke & dementia, and (ii) recovery after stroke. He has complementary research foci investigating the hypothesis that (maladaptive) brain plasticity is crucial for the development of vascular risk factors leading to stroke and for the (lack of) recovery after stroke, and that brain plasticity can be beneficially modified. He uses multimodal brain imaging to understand basic neurophysiological mechanisms underlying human brain plasticity in cortical and subcortical brain areas, and their interaction. He is a founding member of numerous organizations (including the International Organization for Human Brain Mapping) and contributes to several nationally and internationally funded large-scale research projects. He is a member of the Leipzig Research Center for Civilization Diseases where he has spearheaded the collection of multimodal imaging and comprehensive behavioral and clinical outcome data in a population of over 2800 adults.
Arno Villringer, PhD Director
Max Planck Institute for Human Cognitive and Brain Sciences
Dr. Thomas Wolever obtained a Bachelor of Medicine and Bachelor of Surgery from Oxford University, UK in 1980, a PhD in Nutritional Sciences from the University of Toronto in 1986 and a Doctorate in Medicine from Oxford University in 1993. His current position is Professor and Graduate Coordinator in the Department of Nutritional Sciences, University of Toronto. He also has the following cross appointments: Professor, Department of Medicine, University of Toronto and Member of Active Medical Staff, Division of Endocrinology and Metabolism, St. Michael’s Hospital, Toronto. His research interests are the effects of dietary carbohydrates on human physiology and metabolism. He is, perhaps, most well known for work on the glycaemic index which he first developed with Dr. David Jenkins, along with other collaborators, while he was a medical student. He has written or co-authored over 340 papers in peer-reviewed scientific journals, and also authored a book entitled The Glycaemic Index: A Physiological Classification of Dietary Carbohydrate published in 2006 by CABI. In 1997 he founded GI Testing, Inc. to provide confidential GI testing services to industry. To cope with the high demand for GI testing and to enable a wider range of clinical research services to be provided, Glycemic Index Laboratories, Inc. was formed in 2004; a corporation of which he is President. More important than anything else, he is married with three children aged 30, 28 and 21 years. He enjoys orienteering, cycling and recorder playing.
Thomas Wolever, PhD Professor
Department of Nutritional Sciences
University of Toronto